Compare WVE & PLAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | WVE | PLAB |
|---|---|---|
| Founded | 2012 | 1969 |
| Country | Singapore | United States |
| Employees | 317 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Semiconductors |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 2.0B |
| IPO Year | 2015 | 1995 |
| Metric | WVE | PLAB |
|---|---|---|
| Price | $5.68 | $28.61 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 16 | 3 |
| Target Price | $29.81 | ★ $44.33 |
| AVG Volume (30 Days) | ★ 3.9M | 2.0M |
| Earning Date | 04-28-2026 | 05-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 9.09 |
| EPS | N/A | ★ 0.74 |
| Revenue | $3,704,000.00 | ★ $535,276,000.00 |
| Revenue This Year | N/A | $6.70 |
| Revenue Next Year | $85.67 | $4.96 |
| P/E Ratio | ★ N/A | $39.95 |
| Revenue Growth | ★ 149.43 | 18.77 |
| 52 Week Low | $5.02 | $18.04 |
| 52 Week High | $21.73 | $56.00 |
| Indicator | WVE | PLAB |
|---|---|---|
| Relative Strength Index (RSI) | 35.24 | 27.80 |
| Support Level | $5.02 | $21.52 |
| Resistance Level | $7.65 | $38.00 |
| Average True Range (ATR) | 0.32 | 2.41 |
| MACD | 0.00 | -1.58 |
| Stochastic Oscillator | 10.14 | 1.52 |
WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, combines multiple modalities, chemistry innovation, and deep insights into human genetics to deliver scientific breakthroughs that treat both rare and prevalent disorders. Its toolkit of RNA-targeting modalities includes RNA editing, antisense silencing, and RNA interference, providing capabilities for designing and sustainably delivering candidates that optimally address disease biology. Its programs are for rare and prevalent diseases, including alpha-1 antitrypsin deficiency, obesity, Duchenne muscular dystrophy, and Huntington's disease.
Photronics Inc is a U.S.-based company principally engaged in the manufacturing of photomasks, which are high-precision photographic quartz or glass plates containing microscopic images of electronic circuits. Photomasks are a key element in the manufacture of integrated circuits (ICs) and flat-panel displays (FPDs) and are used as masters to transfer circuit patterns onto semiconductor wafers and FPD substrates during fabrication, as well as to a lesser extent, other types of electrical and optical components. The Company has manufacturing facilities in Taiwan, China, South Korea, the United States, and Europe, and generates revenue globally, with Taiwan contributing the majority of total revenue.